Trial Profile
24 Week Open Label, Single Arm Study of Colesevelam in High Risk South Asians With Suboptimal LDL-c Levels Despite Maximally Tolerated Statin Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2020
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary)
- Indications Coronary artery disease; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms CLASS-ACT
- 22 Jan 2020 Status changed from recruiting to completed.
- 26 Oct 2017 Planned End Date changed from 1 Dec 2017 to 28 Feb 2018.
- 26 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 15 Feb 2018.